Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.05 USD
Change Today 0.00 / 0.00%
Volume 0.0
VNAPF On Other Exchanges
Symbol
Exchange
London
OTC US
Frankfurt
As of 4:30 PM 04/25/15 All times are local (Market data is delayed by at least 15 minutes).

Insiders at verona pharma plc (VNAPF)

Name (Connections)Board RelationshipsTitleType of Board MemberAge
Sven Karlsson Ph.D.9 RelationshipsChief Executive Officer and Executive DirectorChief Executive Officer60
Biresh Roy 9 RelationshipsChief Financial Officer and Executive DirectorChief Financial Officer52
Claire Poll B.A., B Juris, LLB, ASIA13 RelationshipsExecutive Director and Member of Audit CommitteeSenior Key Executive--

Other Board Members on Board*

Name (Connections)Board RelationshipsType of Board MemberPrimary CompanyAge
David Ebsworth Ph.D. 29 RelationshipsChairman of the BoardVifor Ltd.61
Stuart Bottomley 9 RelationshipsMember of the Board of DirectorsVerona Pharma plc--
Trevor Jones CBE, Ph.D., DSc FKC FPS FRSC Hon FRCP FBPharmcolS 61 RelationshipsMember of the Board of DirectorsSigma Tau Pharmasource, Inc.72
Patrick Humphrey B.Pharm. Hons Ph.D., D.Sc OBE 24 RelationshipsMember of the Board of DirectorsVerona Pharma plc69
Mario Cazzola 9 RelationshipsMember of Advisory BoardVerona Pharma plc--
Paul O'Byrne M.D., FRCPC, FRCPI, FCCP 67 RelationshipsMember of Advisory BoardVerona Pharma plc--
Klaus Rabe 9 RelationshipsMember of Advisory BoardVerona Pharma plc--
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VNAPF:US $0.05 USD 0.00

VNAPF Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for VNAPF.
View Industry Companies
 

Industry Analysis

VNAPF

Industry Average

Valuation VNAPF Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 3.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VERONA PHARMA PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.